<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00487084</url>
  </required_header>
  <id_info>
    <org_study_id>0524-021</org_study_id>
    <nct_id>NCT00487084</nct_id>
  </id_info>
  <brief_title>Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia</brief_title>
  <official_title>Interaction Between Epidural 2-chloroprocaine and Epidural Morphine: Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidural chloroprocaine is often used in obstetrical anesthesia because of its fast onset and
      short duration. These properties make it an ideal drug to use for epidural anesthesia in
      patients undergoing postpartum tubal ligation. When epidural morphine is given after
      chloroprocaine, there is a decreased efficacy of analgesia as compared to lidocaine (1).
      Several studies have hypothesized a specific opioid receptor mediated antagonism of
      chloroprocaine (2,3). Karambelkar raised the question whether this decreased efficacy is due
      to a disparity between the time the chloroprocaine anesthesia resolves and the onset of
      epidural morphine analgesia, resulting in a time window of pain (2). The duration of action
      of epidural 2-CP anesthesia is 30-45 minutes and the onset of epidural morphine analgesia is
      60-70 minutes, therefore the regression of sensory blockade before the onset of the morphine
      analgesia could result in a window of pain (2). Hess and colleagues studied epidural morphine
      analgesia and women who had a Cesarean delivery under spinal bupivacaine anesthesia (3).
      Subjects were randomized to receive epidural 2-CP and morphine or epidural saline and
      morphine. There was no difference in postoperative analgesia between the two groups (3 and
      personal communication, Dr. Philip Hess). A literature search cross referencing epidural
      chloroprocaine, using Pub Med, did not produce any articles comparing epidural morphine given
      before the procedure (in an attempt to time the onset of analgesia with the resolution of
      chloroprocaine anesthesia) to the standard administration time after the procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women undergoing post partum tubal ligation with an epidural in-situ will be randomly double
      blindedly selected into one of three groups for pain control. The groups are epidural 1)
      epidural morphine-chloroprocaine 2) epidural chloroprocaine-morphine 3) epidural
      morphine-lidocaine. Groups 1 and 3 will receive morphine 30 minutes prior to local anesthetic
      dosing followed by saline placebo after local dosing. Group 2 will receive placebo 30 minutes
      prior to local anesthetic dosing followed by epidural morphine. Pain scores and supplemental
      analgesic requirements will be evaluated 30 minutes, 1hr, 2hr, 4hr and every 4 hrs for the
      first 24hrs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of Continuing Analgesia</measure>
    <time_frame>48 hours</time_frame>
    <description>Time to first request for supplemental analgesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Supplemental Analgesia in First 90 Minutes</measure>
    <time_frame>90 min</time_frame>
    <description>Participants requesting supplemental analgesia in the first 90 minutes following study drug</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Verbal Rating Score (0 to 10) for Pain (VRPS)</measure>
    <time_frame>At recovery room entry</time_frame>
    <description>Verbal Rating Pain Score (VRPS) at time of post-anesthesia recovery room entry, where 0 = no pain and 10 = worst pain imaginable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Supplemental Analgesia in First 48 Hours</measure>
    <time_frame>48 hours</time_frame>
    <description>Participants requesting supplemental analgesia in first 48 hours</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">136</enrollment>
  <condition>Labor</condition>
  <condition>Analgesia, Epidural</condition>
  <arm_group>
    <arm_group_label>morphine - 2CP-saline (MCS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline-2CP-morphine (SCM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>saline will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level;morphine will be administered at skin incision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline-lidocaine-morphine (SLM)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Saline will be administered 30 min prior to epidural anesthesia; lidocaine will be used to achieve a T4 level; morphine will be administered at skin incision</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine-CP-saline (MCS)</intervention_name>
    <description>3mg of preservative free morphine will be administered epidurally 30 min prior to epidural anesthesia. Epidural 3% 2CP will be used to achieve a T4 dermatomal level for surgical anesthesia for PPTL. 6ml of epidural saline will be administered at skin incision</description>
    <arm_group_label>morphine - 2CP-saline (MCS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline-2CP-morphine (SCM)</intervention_name>
    <description>6ml of saline will be administered epidurally 30 min prior to epidural anesthesia. Epidural 3% 2CP will be used to achieve a T4 dermatomal level for surgical anesthesia for PPTL. 3mg of preservative free morphine will be administered at skin incision</description>
    <arm_group_label>saline-2CP-morphine (SCM)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline-lidocaine-morphine (SLM)</intervention_name>
    <description>3mg of preservative free morphine will be administered epidurally 30 min prior to epidural anesthesia. Epidural 2% lidocaine with epinephrine 1:200,000 will be used to achieve a T4 dermatomal level for surgical anesthesia for PPTL. 6ml of epidural saline will be administered at skin incision</description>
    <arm_group_label>saline-lidocaine-morphine (SLM)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with an epidural catheter in situ for labor analgesia, status post a
             vaginal delivery, and scheduled for a postpartum tubal ligation under epidural
             anesthesia will be eligible

        Exclusion Criteria:

          -  Allergy/hypersensitivity to morphine

          -  Allergy/hypersensitivity to ester-linked local anesthetics or para-amino benzoic acid
             (PABA)

          -  Body Mass Index &gt;40 kg/m2

          -  Patients using chronic opioids

          -  History of obstructive sleep apnea

          -  Any contraindication to epidural anesthesia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cynthia A Wong, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Eisenach JC, Schlairet TJ, Dobson CE 2nd, Hood DH. Effect of prior anesthetic solution on epidural morphine analgesia. Anesth Analg. 1991 Aug;73(2):119-23.</citation>
    <PMID>1854026</PMID>
  </reference>
  <reference>
    <citation>Karambelkar DJ, Ramanathan S. 2-Chloroprocaine antagonism of epidural morphine analgesia. Acta Anaesthesiol Scand. 1997 Jun;41(6):774-8.</citation>
    <PMID>9241341</PMID>
  </reference>
  <reference>
    <citation>Camann WR, Hartigan PM, Gilbertson LI, Johnson MD, Datta S. Chloroprocaine antagonism of epidural opioid analgesia: a receptor-specific phenomenon? Anesthesiology. 1990 Nov;73(5):860-3.</citation>
    <PMID>2173443</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2007</study_first_submitted>
  <study_first_submitted_qc>June 14, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2007</study_first_posted>
  <results_first_submitted>February 9, 2011</results_first_submitted>
  <results_first_submitted_qc>March 14, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 18, 2011</results_first_posted>
  <last_update_submitted>March 17, 2014</last_update_submitted>
  <last_update_submitted_qc>March 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Cynthia Wong</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>tubal ligation</keyword>
  <keyword>chloroprocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Chloroprocaine</mesh_term>
    <mesh_term>Procaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>136 subjects approached and assessed for eligibility</recruitment_details>
      <pre_assignment_details>Excluded from randomization (n=37), 26 refused to participate, 11 did not meet exclusion criteria</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Morphine - 2 Chloroprocaine - Saline (MCS)</title>
          <description>morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision</description>
        </group>
        <group group_id="P2">
          <title>Saline-2 Chloroprocaine - Morphine (SCM)</title>
          <description>saline will be administered 30 min prior to epidural anesthesia; 2-chloroprocaine will be used to achieve a T4 level; morphine will be administered at skin incision</description>
        </group>
        <group group_id="P3">
          <title>Saline - Lidocaine - Morphine (SLM)</title>
          <description>Saline administered 30 minutes prior to lidocaine to achieve a T4 anesthesia level. Morphine administered at skin incision.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
                <participants group_id="P3" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not receive intervention</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Morphine - 2 Chloroprocaine - Saline (MCS)</title>
          <description>morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision</description>
        </group>
        <group group_id="B2">
          <title>Saline-2 Chloroprocaine - Morphine (SCM)</title>
          <description>saline will be administered 30 min prior to epidural anesthesia; 2-chloroprocaine will be used to achieve a T4 level; morphine will be administered at skin incision</description>
        </group>
        <group group_id="B3">
          <title>Saline - Lidocaine - Morphine (SLM)</title>
          <description>Saline administered 30 minutes prior to lidocaine to achieve a T4 anesthesia level. Morphine administered at skin incision.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="33"/>
            <count group_id="B4" value="99"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33" spread="4"/>
                    <measurement group_id="B2" value="31" spread="5"/>
                    <measurement group_id="B3" value="29" spread="4"/>
                    <measurement group_id="B4" value="30" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Duration of Continuing Analgesia</title>
        <description>Time to first request for supplemental analgesia</description>
        <time_frame>48 hours</time_frame>
        <population>All participants receiving the intervention were analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Morphine - 2 Chloroprocaine - Saline (MCS)</title>
            <description>morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision</description>
          </group>
          <group group_id="O2">
            <title>Saline-2 Chloroprocaine - Morphine (SCM)</title>
            <description>saline will be administered 30 min prior to epidural anesthesia; 2-chloroprocaine will be used to achieve a T4 level; morphine will be administered at skin incision</description>
          </group>
          <group group_id="O3">
            <title>Saline - Lidocaine - Morphine (SLM)</title>
            <description>Saline administered 30 minutes prior to lidocaine to achieve a T4 anesthesia level. Morphine administered at skin incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Continuing Analgesia</title>
          <description>Time to first request for supplemental analgesia</description>
          <population>All participants receiving the intervention were analyzed</population>
          <units>hours</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.6" lower_limit="4.4" upper_limit="52.7"/>
                    <measurement group_id="O2" value="2.2" lower_limit="0" upper_limit="4.8"/>
                    <measurement group_id="O3" value="25.8" lower_limit="10.7" upper_limit="40.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>A sample of 56 was estimated to have an 80% power to detect a 30% difference in the proportion of subjects with continuing analgesia in the MCS versus the SCM groups when 50% of the subjects in the SCM had requested supplemental analgesia. 28 subjects was added to compare the influence of time of morphine and 2-chloroprocaine administration to lidocaine-morphine analgesia. The primary outcome was compared using Kaplan-Meier survival analysis and the log-rank test.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.006</p_value>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.83</p_value>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.009</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Verbal Rating Score (0 to 10) for Pain (VRPS)</title>
        <description>Verbal Rating Pain Score (VRPS) at time of post-anesthesia recovery room entry, where 0 = no pain and 10 = worst pain imaginable</description>
        <time_frame>At recovery room entry</time_frame>
        <population>Verbal Rating Score for Pain (0-10) where 0 = no pain and 10 = worst pain imaginable</population>
        <group_list>
          <group group_id="O1">
            <title>Morphine - 2 Chloroprocaine - Saline (MCS)</title>
            <description>morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision</description>
          </group>
          <group group_id="O2">
            <title>Saline-2 Chloroprocaine - Morphine (SCM)</title>
            <description>saline will be administered 30 min prior to epidural anesthesia; 2-chloroprocaine will be used to achieve a T4 level; morphine will be administered at skin incision</description>
          </group>
          <group group_id="O3">
            <title>Saline - Lidocaine - Morphine (SLM)</title>
            <description>Saline administered 30 minutes prior to lidocaine to achieve a T4 anesthesia level. Morphine administered at skin incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Rating Score (0 to 10) for Pain (VRPS)</title>
          <description>Verbal Rating Pain Score (VRPS) at time of post-anesthesia recovery room entry, where 0 = no pain and 10 = worst pain imaginable</description>
          <population>Verbal Rating Score for Pain (0-10) where 0 = no pain and 10 = worst pain imaginable</population>
          <units>Scores on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="4.5"/>
                    <measurement group_id="O2" value="2" lower_limit="1.8" upper_limit="4.0"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Supplemental Analgesia in First 90 Minutes</title>
        <description>Participants requesting supplemental analgesia in the first 90 minutes following study drug</description>
        <time_frame>90 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Morphine - 2 Chloroprocaine - Saline (MCS)</title>
            <description>morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision</description>
          </group>
          <group group_id="O2">
            <title>Saline-2 Chloroprocaine - Morphine (SCM)</title>
            <description>saline will be administered 30 min prior to epidural anesthesia; 2-chloroprocaine will be used to achieve a T4 level; morphine will be administered at skin incision</description>
          </group>
          <group group_id="O3">
            <title>Saline - Lidocaine - Morphine (SLM)</title>
            <description>Saline administered 30 minutes prior to lidocaine to achieve a T4 anesthesia level. Morphine administered at skin incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Supplemental Analgesia in First 90 Minutes</title>
          <description>Participants requesting supplemental analgesia in the first 90 minutes following study drug</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Supplemental Analgesia in First 48 Hours</title>
        <description>Participants requesting supplemental analgesia in first 48 hours</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Morphine - 2 Chloroprocaine - Saline (MCS)</title>
            <description>morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision</description>
          </group>
          <group group_id="O2">
            <title>Saline-2 Chloroprocaine - Morphine (SCM)</title>
            <description>saline will be administered 30 min prior to epidural anesthesia; 2-chloroprocaine will be used to achieve a T4 level; morphine will be administered at skin incision</description>
          </group>
          <group group_id="O3">
            <title>Saline - Lidocaine - Morphine (SLM)</title>
            <description>Saline administered 30 minutes prior to lidocaine to achieve a T4 anesthesia level. Morphine administered at skin incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Supplemental Analgesia in First 48 Hours</title>
          <description>Participants requesting supplemental analgesia in first 48 hours</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.20</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Morphine - 2 Chloroprocaine - Saline (MCS)</title>
          <description>morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision</description>
        </group>
        <group group_id="E2">
          <title>Saline-2 Chloroprocaine - Morphine (SCM)</title>
          <description>saline will be administered 30 min prior to epidural anesthesia; 2-chloroprocaine will be used to achieve a T4 level; morphine will be administered at skin incision</description>
        </group>
        <group group_id="E3">
          <title>Saline - Lidocaine - Morphine (SLM)</title>
          <description>Saline administered 30 minutes prior to lidocaine to achieve a T4 anesthesia level. Morphine administered at skin incision.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>We used a single 30-minute interval between morphine and 2-chloroprocaine administration and additional investigation is warranted to determine the optimum interval for administration.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Cynthia A. Wong,M.D.</name_or_title>
      <organization>Northwestern University</organization>
      <phone>630-472-3555</phone>
      <email>c-wong2@northwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

